Fulcrum Therapeutics (FULC) Q2 2025 Earnings

May 1Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.41
0.02
0.44
0.87

Details

Expected EPS
-0.294
Actual EPS
-0.28
Surprise EPS
0.01
Surprise Percent
+4.76%

Description

⁨Fulcrum Therapeutics⁩ (⁦FULC⁩) has reported earnings of ⁦-0.28⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts